Matches 1 - 20 out of 20


Match Document Document Title
DE202013012839U1 New polymorphs from LNnT  
A crystalline LNnT polymorph IV, characterized in that it shows X-ray powder diffraction reflections based on a measurement using CuKa radiation at 2Θ angles of 8.16 and 15.41, more preferably at...
DE202017007249U1 Separation of oligosaccharides from the fermentation broth  
A solid sialylated oligosaccharide, the solid sialylated oligosaccharide being a spray dried or crystalline acidic human milk oligosaccharide selected from 6'-sialylylactose (6'-SL),...
DE102017002810A1 Sialic acid derivatives with CC triple bond and their preparation  
Sialic acid derivatives containing a CC triple bond are described, processes for their preparation, conjugates prepared therefrom and pharmaceutical compositions containing them.
DE102006053637B4 New fluorine-substituted 1,4-benzothiepin-1,1-dioxide derivatives, medicaments containing these compounds and their use  
Compounds of formula I, in what mean X NH; R1 (C1-C6) Alkyl; R4 F; R4 'H, F; R2, R2 ', R3, R3', R5, R5 'independently of one another H, F, Cl, Br, I, OH, - (CH2) -OH, CH2F, CHF2, CF3, NO2, N3, CN,...
DE102006053635B4 New 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl radicals, medicaments containing these compounds and their use  
Compounds of the formula and their pharmaceutically acceptable salts.
DE102008024309A1 New tetrahydro-pyran compounds useful to prepare 2-desoxy-2-(F-18)fluoroglucosyl-1-azide, which is useful for F-18-glycosylation of bioactive alkynyl or ethinyl derivatized molecule to form conjugated tetrahydro-pyran biomolecule  
Tetrahydro-pyran compounds (I) are new. Tetrahydro-pyran compounds of formula (I) are new. 3 of R 1-R 4= a leaving group comprising OAc and the other is OSO 2R', and R'= methyl, trifluoromethyl or...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102005033099A1 New 1,4-benzothiazepine-1,1-Dioxidderivat with improved properties, process for its preparation, pharmaceuticals comprising this compound and its use  
The Invention relates to the compound of formula A and physiologically acceptable Salts. The connection is suitable for. B. as Hypolipidämikum.
DE19911504B4 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in aqueous Phase, characterized in that the oxidation catalytic using a noble metal catalyst, the precious...
DE19911504A1 A process for the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds  
For the industrial oxidation of alcohols, aldehydes or polyhydroxy compounds in the aqueous phase, the oxidation is carried out catalytically using a noble metal catalyst formed from...
DE19531264A1 Cationic unsaturated saccharides and polymers prepared therefrom and their use  
cationic, unsaturated saccharides of the formula I $ F1 in which $ AR ↑ 1 ↑ has a deoxysaccharide radical having 1 to 20 monomer units, $ AR ↑ 2 ↑ has the same meaning as R ↑ 1 ↑ or C ↓ 1 ↓ -C ↓...
DE19503423A1 Anti-adhesive agents  
The invention concerns the use of a compound or a number of compounds from the group of the carbohydrates or carbohydrate derivatives as anti-adhesive active principles directed against...
DE4215558A1 Acidic catalysts  
Acid catalysts are prepared by reacting short-chain triglycerides having the formula (I), in which R<1>, R<2> and R<3> represent independently from each other alkyl rests with 1 to 4 carbon atoms,...
DE3927801A1 METHOD FOR THE ENZYMATIC SYNTHESIS galactosylated GLYCOPROTEIN BLOCKS  
Synthesis of Gal-β (1 → 4) -GlcNAc-β (1 → N) -Asn and Gal-β (1 → 4) -GlcNAc-β (1 → 4) -GlcNAc-β (1-N) - L-Asn can be carried out from the precursors aspartyl-N-acetylglucosamine or...
DE3925727A1 USE OF 2-HYDROXY-3-aminopropionic acid derivatives, in BLEACH STABILIZERS AND GERUESTSTOFFE IN WASHING AND CLEANING AGENTS  
Use of 2-hydroxy-3-aminopropionic acid derivatives of the formula I $ F1 in the X for hydrogen, an alkali metal or ammonium, which may be substituted by C ↓ 1 ↓ -C ↓ 4 ↓ -alkyl groups or C ↓ 1 ↓...
DE3829552A1 MILK INGREDIENTS, METHOD FOR THE PRODUCTION AND MEANS THAT THESE COMPONENTS CONTAIN  
Constituents of the non-protein-nitrogen fraction of untreated raw milk or fresh milk have a characteristic pharmacological activity.
DE3812681A1 SUBSTITUTED N-glycosyl, PROCESS FOR THEIR PRODUCTION AND USE AS DRUGS  
The invention relates to novel N-glycosylamides of the formula I $ F1 in which R1 represents a saturated alkyl radical or a simple, denotes di- or triunsaturated alkenyl radical having up to 50...
DE3737523A1 USE OF SUBSTITUTED hydroxypiperidines AS ANTIVIRAL AGENTS  
The invention relates to the use of known, substituted hydroxypiperidines as antiviral agents in human and veterinary medicine.
DE3531102A1 Epiminopyranosides, process for their preparation, and their use  
3,4-Dideoxy-3,4-epiminopyranosides are described, in which the free hydroxy group is in the 2-position in the trans-position to the epimino group, and 2,3-dideoxy-2,3-epiminopyranosides in which...

Matches 1 - 20 out of 20